
Quanterix Corporation QTRX
$ 3.55
-8.97%
Annual report 2025
added 03-02-2026
Country |
|
IPO year |
2017 |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
42.6 M |
Market Cap[1] |
$ 151 M |
EBITDA (LTM) |
$ -106 M |
P/E (LTM) |
-1.73 |
P/S (LTM) |
1.27 |
EPS (LTM) |
-2.25 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Beyond Air
XAIR
|
$ 0.72 | 3.86 % | $ 48.7 M | Nasdaq Global Select Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Xtant Medical Holdings
XTNT
|
$ 0.54 | -4.43 % | $ 72.2 M | NYSE American | ||
|
Zimmer Biomet Holdings
ZBH
|
$ 88.29 | -0.97 % | $ 17.9 B | NYSE,SPB | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Align Technology
ALGN
|
$ 165.93 | -6.43 % | $ 12.4 B | Nasdaq Global Select Market,SPB | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Alphatec Holdings
ATEC
|
$ 10.9 | -5.43 % | $ 1.64 B | Nasdaq Global Select Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Accuray Incorporated
ARAY
|
$ 0.39 | 4.51 % | $ 40.1 M | Nasdaq Global Select Market | ||
|
Abbott Laboratories
ABT
|
$ 104.33 | -0.23 % | $ 182 B | NYSE,SPB | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Boston Scientific Corporation
BSX
|
$ 69.42 | -1.07 % | $ 103 B | NYSE,SPB | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
CONMED Corporation
CNMD
|
$ 34.68 | -5.35 % | $ 1.08 B | NYSE,SPB | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.6 | -0.18 % | $ 32.7 M | Nasdaq Capital Market | ||
|
Aethlon Medical
AEMD
|
$ 2.14 | -5.73 % | $ 3.34 M | Nasdaq Capital Market | ||
|
Edwards Lifesciences Corporation
EW
|
$ 79.45 | -3.23 % | $ 46.5 B | NYSE,SPB | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
AdaptHealth Corp.
AHCO
|
$ 11.11 | -2.63 % | $ 1.5 B | Nasdaq Capital Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 15.65 | -4.31 % | $ 367 M | Nasdaq Global Select Market,SPB | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Ra Medical Systems
RMED
|
- | 10.0 % | $ 610 K | NYSE American | ||
|
Myomo
MYO
|
$ 0.67 | -1.26 % | $ 28 M | NYSE American | ||
|
Penumbra
PEN
|
$ 335.28 | -0.34 % | $ 13 B | NYSE,SPB | ||
|
Inspire Medical Systems
INSP
|
$ 49.77 | -1.35 % | $ 1.46 B | NYSE,SPB | ||
|
Pulmonx Corporation
LUNG
|
$ 1.17 | -5.65 % | $ 47.6 M | Nasdaq Global Select Market | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
NuVasive
NUVA
|
- | - | $ 2.07 B | Nasdaq Global Select Market,SPB | ||
|
Nevro Corp.
NVRO
|
- | - | $ 217 M | NYSE,SPB | ||
|
Surgalign Holdings
SRGA
|
- | -32.98 % | $ 1.68 M | Nasdaq Global Select Market | ||
|
STRATA Skin Sciences
SSKN
|
- | - | $ 6.6 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.